Episode
The PINK PILL for Women's Sexual Desire - Why it Took 10x Longer for Women's Addyi vs Men's Viagara with Cindy Eckert & Julie Bristow
- Podcast
- Bite Back with Abbey Sharp
- Published
- Mar 17, 2026
- Duration seconds
- 1026
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/bite-back-with-abbey-sharp-7043901/episodes/the-pink-pill-for-women-s-sexual-desire-why-it-took-10x-longer-for-women-s-addyi-vs-men-s-viagara-with-cindy-eckert-julie-bristow/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/bite-back-with-abbey-sharp-7043901/the-pink-pill-for-women-s-sexual-desire-why-it-took-10x-longer-for-women-s-addyi-vs-men-s-viagara-with-cindy-eckert-julie-bristow.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In today’s episode of Bite Back with Abbey Sharp, we explore the politics, science, and cultural debate surrounding women’s sexual desire and the development of the first FDA-approved medication for low libido. Joined by Julie Bristow, executive producer of the documentary The Pink Pill: Sex, Drugs, and Who Has Control, and Cindy Eckert, founder of Sprout Pharmaceuticals, we unpack the long road to bringing Addyi to market and what the fight for a “female Viagra” reveals about gender bias in medicine, sexual autonomy, and whose health needs are prioritized.